Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ:BIIB)

195.62 -0.90 (-0.46%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Biogen Idec

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
A Letter From Alphonse Galdes, Ph.D., Head of Pharmaceutical Operations and Technology at Biogen: It's Time for Companies to Act Like the Climate Crisis Is a Health Crisis
SOURCE: Biogen 
Via 3BL Media
Topics Climate Change Death Emissions
News headline image
MIT Collaborates With Biogen on Three-Year, $7 Million Initiative to Address Climate, Health, and Equity
SOURCE: Biogen 
Via 3BL Media
Topics Climate Change
MSM Students to Participate in Biogen's Summer Health Equity Fellowship Program
SOURCE: Biogen 
Via 3BL Media
News headline image
Sage Therapeutics and Biogen Announce Plans to Submit a New Drug Application (NDA) for Zuranolone to the U.S. Food & Drug Administration in the Second Half of 2022 with Rolling Submission Expected to Start in Early 2022
From Sage Therapeutics, Inc.
Via Business Wire
Enel X Collaborates With Biogen to Electrify Take-Home Vehicle Fleet in North America
SOURCE: Biogen 
Via 3BL Media
Topics Climate Change Economy Electric Vehicles
Kenan Fellows Program and Biogen Foundation Collaborate to Advance Workforce Education
SOURCE: Biogen 
Via 3BL Media
News headline image
Biogen Ranks #17 on 100 Best Corporate Citizens of 2021
SOURCE: Biogen 
Via 3BL Media
Topics Climate Change
News headline image
Healthy Climate, Healthy Lives: Advancing Strategic Collaborations
SOURCE: Biogen 
Via 3BL Media
Topics Emissions
Global Atopic Dermatitis Treatment Market Size Is Projected To Be Worth US$21.80 Billion By 2026
Palm Beach, FL –October 12, 2021 – FinancialNewsMedia.com News Commentary – Atopic Dermatitis is an inflammatory skin disease, and the degree of its severity varies from patient to patient. It usually... 
Via FinancialNewsMedia
News headline image
Healthy Climate, Healthy Lives: Engaging Employees and Suppliers
SOURCE: Biogen 
Via 3BL Media
Topics Emissions
News headline image
Healthy Climate, Healthy Lives: Fossil Fuel Free Operations
SOURCE: Biogen 
Via 3BL Media
Topics Emissions
News headline image
Biogen Issues First Progress Report of its Signature Healthy Climate, Healthy Lives™ Initiative
SOURCE: Biogen 
Via 3BL Media
Topics Emissions Supply Chain
Alzheimer’s Treatment Market Is Anticipated To Reach $2 Billion By The End Of 2027
Via FinancialNewsMedia
Topics Death
News headline image
Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder
From Sage Therapeutics, Inc.
Via Business Wire
Biogen and Eisai Launch Multiple Initiatives to Help Patients With Alzheimer's Disease Access ADUHELM™
SOURCE: Biogen 
Via 3BL Media
Topics Intellectual Property
Biogen and the Biogen Foundation Commit $500,000 in Support to Address COVID-19 in India and Around the World
SOURCE: Biogen 
Via 3BL Media
News headline image
Biogen, Americares and Harvard Chan C-CHANGE Help Community Health Clinics Address Climate Risks
SOURCE: Biogen 
Via 3BL Media
News headline image
Biogen Employees Engage in a Week-Long Series of Open Dialogues to Enhance DE&I Understanding
SOURCE: Biogen 
Via 3BL Media
Topics Climate Change
News headline image
Biogen Receives Honorable Mention From Fast Company's World Changing Ideas Awards
SOURCE: Biogen 
Via 3BL Media
Topics Supply Chain
News headline image
Biogen Releases 2020 Year in Review Demonstrating Its Commitment to Transparency and Progress across Environmental, Social and Governance Metrics
SOURCE: Biogen 
Via 3BL Media
Topics Emissions
New Project to Help Community Health Clinics Address Climate Risks Launched by Biogen, Americares and Harvard Chan C-CHANGE
SOURCE: Biogen 
Via 3BL Media
Topics Climate Change
News headline image
WBCSD Member Companies Launch New Project to Advance Global Health and Wellbeing
SOURCE: Biogen 
Via 3BL Media
Topics Death
Global Dementia Drugs Market Expected to Exceed $19.6 Billion In 2026
Via FinancialNewsMedia
Topics Death
News headline image
The Road to a 100% Electric Vehicle Fleet
SOURCE: Biogen 
Via 3BL Media
Topics Electric Vehicles
News headline image
Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
From Sage Therapeutics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.